TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong · Delayed Price · Currency is HKD 47.66
-0.90 (-1.85%)
May 7, 2026, 4:08 PM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 19.62 billion as of May 7, 2026.
Market Cap
19.62B
Enterprise Value
19.08B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
47.66
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 19.62B, an increase of 110.38%. That is a compound annual growth rate of 135.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 19.62B | -56.97% |
| Dec 31, 2025 | 45.60B | 388.94% |
| Jun 23, 2025 | 9.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genscript Biotech | 29.12B |
| InnoCare Pharma | 27.77B |
| Duality Biotherapeutics | 24.31B |
| Keymed Biosciences | 21.79B |
| Zai Lab | 18.68B |
| Ascletis Pharma | 17.74B |
| Ascentage Pharma Group International | 15.78B |
| Nanjing Leads Biolabs | 15.59B |